Extranodal NK-T Cell Lymphoma in an elderly
Keywords:
Linfoma, Extranodal, Células T/NK, Granuloma letal de la línea media, Linfoma no Hodgkin, Virus Epstein-Barr.Abstract
The case report of a 64 years patient is described, who went to the Stomatology Service of Julio Castillo Polyclinic, Ciego de Ávila province, due to a significant inflammation in the upper anterior sector of the maxilla, covered by a whitish pseudomembrane with stench. He was referred to secondary care due to the clinical suspicion of squamous cell carcinoma. Several biopsies were carried out, which confirmed the diagnosis of extranodal NK-T cells lymphoma. After the progression of the lesions and its state, it was not possible to apply antineoplastic treatment. The patient survived approximately 7 months
Downloads
References
1. Vázquez Monroy MA, Antonio Martínez A, Estrada Durán DM, Montes Osorio MG. Linfoma extranodal de células T/NK en la región nasal vs mucormicosis. Un reto diagnóstico. An Orl Mex. 2022[citado 19/04/2024];67(3):235-40. Disponible en: https://www.medigraphic.com/pdfs/anaotomex/aom-2022/aom223h.pdf
2. Gentile B, Abaca MC, Senarega A, Rivarola E. Linfoma de células NK extranodal tipo nasal: reporte de un caso exitoso asociado a trasplante de médula ósea. Med Cutan Iber Lat Am. 2022[citado 19/04/2024];50(1). Disponible en: https://www.medicinacutaneaila.com/files/mcut_22_50_1https://www.medicinacutaneaila.com/files/mcut_22_50_1_029-032.pdf_029-032.pdf
3. Mora OE, González MC, García AM, Vargas LV, Morales SD, Urguijo PA. Linfoma nasal de células T/natural killer (LNT/NK). Repert Med Cir. 2023:1-5.
4. Benavides Jiménez MP, Ferreira Cristofori G, Cohen Abtibol R, Tobal Calvo A, Rojas Saurez R. Reporte de caso: Linfoma extranodal de células T/ NK tipo nasal en Costa Rica. Rev Cien Sal Int Conoc. 2023[citado 19/04/2024];7(3). Disponible en: Disponible en: https://revistacienciaysalud.ac.cr/ojs/index.php/cienciaysalud/article/view/649/766
5. Pineda Galindo LF, Carreño Pérez P, Leal Alegre G, Vásquez Jiménez CE, García Aguilar BS. Panhipopituitarismo y mononeuropatía craneal, manifestación de linfoma NK/T que imita tuberculosis meníngea. Rev Med Inst Mex Seguro Soc. 2020[citado 19/04/2024];58(4):522-7. Disponible en: https://www.redalyc.org/journal/4577/457768632021/html/
6. Bernal J, Tuta Quintero E, Balcazar E, Franco D, Kuan JC, Collazos E, et al. Linfoma de células T/natural killer extranodal de tipo nasal enmascarado en una sinusopatía. Rev. cuban. med. mil. 2023[citado 19/04/2024];52(1):e2222. Disponible en: https://revmedmilitar.sld.cu/index.php/mil/article/view/2222
7. García C, Fuertes X, Villegas R, Salinas J, Anze G. Pronóstico desfavorable de linfoma T/NK: reporte de casos. Rev. Méd. La Paz. 2023 [citado 19/04/2024];29(1):69-74. Disponible en: http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S1726-89582023000100069&Ing=es
8. Sosa MA, Crosta C, Villafañe V, Gonzalez Macchi ME. Linfoma extranodal de células NK/T tipo nasal. Rev. Hosp. Priv. Comun. 2022[citado 19/04/2024];23(1). Disponible en: https://www.hpc.org.ar/wp-content/uploads/29-32-Sosa.pdf
9. Rodríguez Miramontes G, Calderón Quiroz ER, Luna De la Sancha FF, Vásquez Guzmán N, Almeida Navarro JS. Linfoma no Hodgkin de células T/NK nasal. Rev. Hematol Méx. 2023;24(3):163-8.
10. Crisol Deza D, Zurita Borja J, Huamán Alvarado I, Medeiros Bascope ML, Huamán Alvarado I. Relato de caso: linfoma de células t/nk extranodal tipo nasal. Rev Colomb Enferm. 2022[citado 19/04/2024];21(3):1-7. Disponible en: https://revistas.unbosque.edu.co/index.php/RCE/article/view/3433/3494
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 MEDISAN

This work is licensed under a Creative Commons Attribution 4.0 International License.
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.